Find Funding Opportunities

The purpose of this notice is to add NINDS-specific research interests in PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)".

The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning from mentored career development awards to research independence and to minimize departures from biomedical research workforce. This supplement program is intended to ensure continuity of research among recipients of mentored career development (K) awards by providing supplemental research support to help sustain the investigators research during a period in which the PD/PI experiences critical life events which have the potential to impact research progress or potential productivity. Administrative supplements must support work within the scope of the original project.

The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diverse talent in the biomedical research workforce. This program supports at-risk investigators as identified in the NIH Next Generation Researchers Initiative (see https://grants.nih.gov/ngri.htm).

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this Notice is to announce that the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Center for Complementary and Integrative Health (NCCIH) encourage new applications to advance research activities relevant to the five strategic priorities identified in the recently released NIH Strategic Plan for Tickborne Disease Research:

The purpose of this notice is to inform applicants of a correction to the Eligibility Information for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed). For this Funding Opportunity Announcement (FOA), "Section III. Eligibility Information" has been corrected to allow intramural participation. This is consistent with the intramural participation language in "Section IV. Application and Submission Information, 7. Other Submission Requirements and Information".

The purpose of this time-sensitive Request for Information (RFI) is to seek input on the Draft ALS Strategic Plan from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, people with genetic risk of ALS, advocates, scientists, clinicians, and the broader community.

The purpose of this notice is to inform applicants of a change to the Key dates and review locus for RFA-NS-19-043 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this notice is to inform applicants of a change to the Key dates and review locus for RFA-NS-19-044 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.